Search results - 484 results
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.
Publication Type: Peer reviewed scientific article Authors: Timothy Devos; Tatjana Geukens; Alexander Schauwvlieghe; Ariën, Kevin K; Cyril Barbezange; Myriam Cleeren; Veerle Compernolle; Nicolas Dauby; Desmecht, Daniel; David Grimaldi; Bart N Lambrecht; A ...
Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
Publication Type: Peer reviewed scientific article Authors: N Dauby; Lucy Catteau; Joris Hautekiet; Marion Montourcy; E Bottieau; Goetghebeur, E; Dominique Van Beckhoven Source: Int J Antimicrob Agents (2020) Health Topics: COVID-19 Service: Épidémiolog ...
Surveillance of ICU-acquired Infections, National Feedback Report, Year 2019
resistance Bloodstream infection european center for disease control Healthcare-associated infection icu-acquired infection intensive care unit nosocomial infection Pneumonia Health Topics: Hospital ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Therapy COVID-19 Female Global Burden of Disease Hospitalization Humans Immunization, Passive Male mortality Respiration, Artificial SAFETY SARS-CoV-2 Standard of Care Treatment Outcome Abstract: ...
All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century.
deaths and the COVID-19 mortality rate per million were calculated for hospitals, nursing homes and other places of death, according to diagnostic status (confirmed/possible infection). To evaluate ...
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
Survey Study Group Source: Antimicrob Resist Infect Control, Volume 9 (2020) Keywords: point prevalence survey; healthcare-associated infections; antimicrobial use; acute care hospitals; Belgium Abstract: ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: report 2018
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Katrien Latour; Goossens, H; Hallin, M; Huang, T D Source: Sciensano, Brussels, Belgium, p.57 (2020) Accession Number: D/2020/14.440/8 Keywords: Antibiotic resistanc ...
SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the 2020 COVID-19 outbreak (SARS-CoV-2 HCW): amended protocol
I Desombere; Veronik Hutse; Isabelle Thomas; Vuylsteke, Bea; Els Duysburgh Source: Sciensano, Brussels, Belgium (2020) Keywords: Belgium COVID-19 HEALTHCARE WORKERS hospital SARS-CoV-2 Seroprevalence well-being ...
The burden of legionnaires' disease in Belgium, 2013 to 2017.
in Belgium between 2013 and 2017 and to estimate its true burden in the Belgian population in 2017, the most recent year for which the necessary data were available. Methods: Belgian hospital discharge ...
ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations.
(persistent crying and somnolence) were not captured by the databases for which outcomes were restricted to hospital discharge diagnoses. CONCLUSION: The database characterisation programs and workflows allowed ...